Common Contracts
2 similar License and Sublicense Agreement contracts by ARCA Biopharma, Inc.
EX-10.1 2 dex101.htm LICENSE AND SUBLICENSE AGREEMENT, DATED OCTOBER 28, 2003 LICENSE AND SUBLICENSE AGREEMENT by and between CPEC L.L.C. and ARCA DISCOVERY, INC.License and Sublicense Agreement • May 5th, 2020 • New York
LICENSE AGREEMENT (this “Agreement”) effective as of October 28, 2003 (“Effective Date”), by and between CPEC, L.L.C., a Delaware limited liability company (“CPEC”) having an office at 99 Hayden Avenue, Suite 200, Lexington, MA 02421 (“CPEC”) and ARCA Discovery, Inc., a corporation organized and existing under the laws of the State of Colorado and having its principal office at 12635 East Montview Boulevard, Suite 100, Aurora, CO 80010 (“ARCA”).
LICENSE AND SUBLICENSE AGREEMENT by and between CPEC L.L.C. and ARCA DISCOVERY, INC.License and Sublicense Agreement • May 15th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • New York
LICENSE AGREEMENT (this “Agreement”) effective as of October 28, 2003 (“Effective Date”), by and between CPEC, L.L.C., a Delaware limited liability company (“CPEC”) having an office at 99 Hayden Avenue, Suite 200, Lexington, MA 02421 (“CPEC”) and ARCA Discovery, Inc., a corporation organized and existing under the laws of the State of Colorado and having its principal office at 12635 East Montview Boulevard, Suite 100, Aurora, CO 80010 (“ARCA”).
